01-01-1970 12:00 AM | Source: Accord Fintech
Vikas Lifecare trades higher on the BSE
News By Tags | #2392 #572 #7178

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

Vikas Lifecare is currently trading at Rs. 4.56, up by 0.08 points or 1.79% from its previous closing of Rs. 4.48 on the BSE.

The scrip opened at Rs. 4.54 and has touched a high and low of Rs. 4.65 and Rs. 4.50 respectively. So far 517743 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 8.15 on 21-Jan-2022 and a 52 week low of Rs. 3.63 on 12-May-2022.

Last one week high and low of the scrip stood at Rs. 4.65 and Rs. 4.39 respectively. The current market cap of the company is Rs. 660.67 crore.

The promoters holding in the company stood at 12.27%, while Institutions and Non-Institutions held 9.58% and 78.15% respectively.

Vikas Lifecare (VLL) has got recognition from Department of Scientific and Industrial Research, Ministry of Science & Technology, Government of India (DSIR) for its In-House R&D Unit(s). This prestigious DSIR recognition set-up by Government of India for benchmarking of the industrial R&D not only acknowledges company’s In-House R&D activities’ supremacy, par excellence research work and innovations, but also encourages to maintain R&D activities at par with international standards.

This DSIR recogination for Company’s In-house R&D Units make it eligible for receiving funds for R&D purpose from various government departments and agencies, and enable to invest further into necessary equipments with reduced or zero tax liability, as R&D Equipments could now be imported with 100% custom duty exemption whereas domestic equipment purchases will attract reduced GST rate of 5% only. Further, in case a product arising out of the R&D unit is patented in India and one more from other country (the US, China, or EU), the product can be sold without any excise duty for a period of three years.

The recognition and the pursuing benefits will help VLL generate additional revenues via manufacturing niche materials and or sales of the in house technology to produce such materials and or roralty fee generated from the technology / technique is let out to other producers of similar materials.

Vikas Lifecare is engaged in trading and manufacturing of polymer, rubber compounds and additives for plastics, synthetic & natural rubber.